GYRE vs LNC · rev $53.5M vs P/E 4.9, rev $9.85B
Gyre Therapeutics Inc. (GYRE) versus Lincoln National Corporation (LNC) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported LNC revenue for 2026-06-30 was $9.85B. Net income was $1.16B. Revenue was up 85.6% from 2026-03-31 to 2026-06-30. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
GYRE currently screens at market cap $589.9M. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
Not investment advice. Open the GYRE and LNC stock pages for the full models.
Not investment advice.